Daniel Douce
YOU?
Author Swipe
View article: Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic
Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic Open
PURPOSE: Guidelines recommend venous thromboembolism (VTE) risk assessment in outpatients with cancer and pharmacologic thromboprophylaxis in selected patients at high risk for VTE. Although validated risk stratification tools are availabl…
View article: Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS)
Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS) Open
Higher and lower hemoglobin concentrations are associated with coronary heart disease (CHD), but whether this risk is consistent across age, sex, and race is unclear. The Reasons for Geographic And Racial Differences in Stroke (REGARDS) st…
View article: Association Of Sickle Cell Trait With Exertional Rhabdomyolysis And Atrial Fibrillation.
Association Of Sickle Cell Trait With Exertional Rhabdomyolysis And Atrial Fibrillation. Open
Sickle cell trait (SCT), sickle cell disease’s carrier status, is a common genetic variant found in many people of African, South Asian, Middle Eastern and Mediterranean descent. While overall considered a benign carrier status, it has bee…
View article: Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
Thrombotic Thrombocytopenic Purpura Associated with Pazopanib Open
A 76-year-old male with metastatic renal carcinoma on day 24 of pazopanib was admitted with complaints of emesis, confusion, and hematuria. Laboratory testing showed acute kidney injury, hyperbilirubinemia, and thrombocytopenia. Scattered …
View article: QLIF-15. PERI-OPERATIVE RISK FACTORS FOR VENOUS THROMBOEMBOLISM DEVELOPMENT IN PATIENTS WITH MALIGNANT GLIOMA
QLIF-15. PERI-OPERATIVE RISK FACTORS FOR VENOUS THROMBOEMBOLISM DEVELOPMENT IN PATIENTS WITH MALIGNANT GLIOMA Open
BACKGROUND: The cumulative incidence of symptomatic venous thromboembolism (VTE) among patients with malignant gliomas (MG) is estimated to be as high as 36% during the course of therapy and confers a 2-fold increased risk of mortality. Th…
View article: Outpatient Treatment of Deep Vein Thrombosis in the United States: The Reasons for Geographic and Racial Differences in Stroke Study
Outpatient Treatment of Deep Vein Thrombosis in the United States: The Reasons for Geographic and Racial Differences in Stroke Study Open
BACKGROUND Outpatient versus inpatient treatment of deep vein thrombosis (DVT) is believed to result in equivalent outcomes with decreased costs. Little is known about the adoption of outpatient DVT treatment in the United States. OBJECTIV…